LIM
Lagoda Investment Management Portfolio holdings
AUM
$177M
This Quarter Return
+0.51%
1 Year Return
+46.81%
3 Year Return
+194.86%
5 Year Return
+427.13%
10 Year Return
+1,154.94%
AUM
$265M
AUM Growth
+$265M
(+0.91%)
Cap. Flow
+$11M
Cap. Flow
% of AUM
4.14%
Top 10 Holdings %
Top 10 Hldgs %
65.79%
Holding
43
New
1
Increased
10
Reduced
23
Closed
5
Top Buys
| 1 |
Johnson & Johnson
JNJ
|
$16M |
| 2 |
Berkshire Hathaway Class A
BRK.A
|
$12M |
| 3 |
Trupanion
TRUP
|
$9.49M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
$5.54M |
| 5 |
Precigen
PGEN
|
$1.44M |
Top Sells
| 1 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$10.2M |
| 2 |
Digimarc
DMRC
|
$9.5M |
| 3 |
TTOO
T2 Biosystems, Inc
TTOO
|
$6.07M |
| 4 |
Ubiquiti
UI
|
$1.96M |
| 5 |
Novo Nordisk
NVO
|
$1.7M |
Sector Composition
| 1 | Healthcare | 28.82% |
| 2 | Financials | 26.89% |
| 3 | Communication Services | 10.48% |
| 4 | Energy | 10.4% |
| 5 | Technology | 8.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Microsoft
MSFT
$3.75T
| $435K | 0.16% |
4,770
-630
| -12% | -$57.5K |
|
27
Mastercard
MA
$535B
| $267K | 0.1% |
1,525
| – | – |
|
28
Brown-Forman Class B
BF.B
$13.8B
| $239K | 0.09% |
4,400
+242
| +6% | +$13.1K |
|
|
Y
29
DELISTED
Alleghany Corporation
Y
| $212K | 0.08% |
345
-220
| -39% | -$135K |
|
30
Coca-Cola
KO
$297B
| $91K | 0.03% |
2,100
-1,550
| -42% | -$67.2K |
|
31
SPDR Gold Trust
GLD
$110B
| $82K | 0.03% |
650
-150
| -19% | -$18.9K |
|
32
Exxon Mobil
XOM
$489B
| $53K | 0.02% |
715
-1,050
| -59% | -$77.8K |
|
33
ConocoPhillips
COP
$124B
| $47K | 0.02% |
800
-315
| -28% | -$18.5K |
|
34
Pfizer
PFE
$142B
| $44K | 0.02% |
1,226
| – | – |
|
35
Abbott
ABT
$229B
| $38K | 0.01% |
639
| – | – |
|
36
Bank of N.T. Butterfield & Son
NTB
$1.85B
| $34K | 0.01% |
750
-50
| -6% | -$2.27K |
|
37
Phillips 66
PSX
$54.1B
| $19K | 0.01% |
197
| – | – |
|
38
AquaBounty Technologies
AQB
$4.15M
| $6K | ﹤0.01% |
1,920
-27
| -1% | -$84 |
|
39
Booking.com
BKNG
$178B
| – | – |
-48
| Closed | -$83K |
|
40
Las Vegas Sands
LVS
$39.1B
| – | – |
-900
| Closed | -$63K |
|
41
Procter & Gamble
PG
$370B
| – | – |
-590
| Closed | -$54K |
|
|
ALXN
42
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| – | – |
-1,000
| Closed | -$120K |
|
43
AbbVie
ABBV
$374B
| – | – |
-489
| Closed | -$47K |
|